Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-label, Monocenter, Trial to Investigate the Efficacy and Tolerability of WO533, a Lactic Acid Containing Vaginal Suppository, in a Panel of Post-menopausal Women Suffering From Vulvovaginal Atrophy (VVA)

NCT04222647 is registered in ClinicalTrials.gov with Dr. August Wolff GmbH & Co. KG Arzneimittel as lead sponsor.

NCT NCT04222647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04222647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-label, Monocenter, Trial to Investigate the Efficacy and Tolerability of WO533, a Lactic Acid Containing Vaginal Suppository, in a Panel of Post-menopausal Women Suffering From Vulvovaginal Atrophy (VVA)
Lead sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel
Phase
Phase 2
Overall status
Completed
Start date
January 27, 2020
Completion date
August 11, 2020
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vulvovaginal atrophy